Reckitt Benckiser Group plc announced the expiration and results of a cash tender offer by its subsidiary, Mead Johnson Nutrition Company, purchasing over $400 million in senior notes due 2044.
In this corporate debt action managed by global financial institutions, Mead Johnson Nutrition Company—a wholly owned subsidiary of Reckitt Benckiser Group plc—reached the expiration time for its cash tender offer and consent solicitation concerning its outstanding long-term debt instruments.
In Plain English: The Clinical Takeaway
- Investors holding the remaining 2044 Senior Notes face modified indenture terms, including the removal of specific restrictive covenants and the release of parent-level guarantees.
- Settlement for validly tendered notes is scheduled for mid-August 2026, delivering total consideration of $898.00 per $1,000 principal amount plus accrued interest.
Transaction Mechanics and Financial Results
According to disclosures released by Reckitt Benckiser Group plc from Slough, United Kingdom, the tender offer targeted the 4.600% Senior Notes due 2044 issued by Mead Johnson Nutrition Company. By the expiration time on August 13, 2026, investors had validly tendered and not withdrawn $400,415,000 in aggregate principal amount of the notes. This substantial uptake leaves $99,585,000 in aggregate principal amount of notes remaining outstanding after the settlement date, which is expected to occur on August 18, 2026.
Holders who participated prior to the deadline receive a total consideration of $898.00 per $1,000 principal amount tendered, alongside accrued and unpaid interest up to the settlement date. The operation was managed on the dealer side by Deutsche Bank Securities Inc. and Merrill Lynch International, with Global Bondholder Services Corporation serving as the tender and information agent.
Indenture Amendments and Guarantee Releases
Alongside the cash tender offer, Mead Johnson Nutrition solicited consents from registered holders to amend the underlying indenture governing the notes. Having secured the requisite consents representing a majority in principal amount of the outstanding notes, the company will execute a supplemental indenture. This legal instrument goes into effect on the settlement date, stripping out substantially all restrictive covenants and certain events of default.
Crucially for the remaining noteholders, the supplemental indenture also releases Reckitt Benckiser Group plc from its parent guarantee on the remaining notes.
| Metric | Value |
|---|---|
| Reference Security & Coupon | 4.600% Senior Notes due 2044 (ISIN: US582839AG14) |
| Initial Principal Amount | $500,000,000 |
| Tendered Principal Amount | $400,415,000 |
| Remaining Principal Amount | $99,585,000 |
| Total Tender Consideration | $898.00 per $1,000 principal amount plus accrued interest |
| Expiration Date | August 13, 2026 |
| Expected Settlement Date | August 18, 2026 |
Contraindications & When to Consult a Doctor
References
- Reckitt Benckiser Group plc. Official Press Release via PR Newswire: Reckitt Announces Expiration and Results of Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044. August 2026.
- Reckitt Benckiser Group plc. Offer to Purchase and Consent Solicitation Statement, Mead Johnson Nutrition Company. Dated August 5, 2026.
- The Bank of New York Mellon Trust Company, N.A. Indenture and Supplemental Indenture documentation regarding 4.600% Senior Notes due 2044.
All data is derived directly from corporate disclosures published in August 2026.
